(MSB) Mesabi Trust - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5906721015

MSB: Iron Ore, Pellets

Mesabi Trust (NYSE:MSB) operates as a royalty trust focused on the iron ore mining industry in the United States. Established in 1961 and headquartered in New York, the trust generates revenue primarily through royalties from iron ore mined at the Peter Mitchell Mine in Minnesota, a key producer of iron ore pellets. The trust does not engage in direct mining operations but collects royalties based on the volume and price of iron ore produced and sold from the mine.

The trusts financial performance is closely tied to the global demand for steel and iron ore, as well as the profitability of its mining operator. Mesabi Trust distributes a significant portion of its income to shareholders in the form of dividends, making it a notable investment for income-focused investors. The trusts operations are relatively straightforward, with minimal overhead costs, as it relies on its operator to manage the mining activities.

Based on the provided data, Mesabi Trusts stock has shown recent strength, with the 20-day moving average (SMA 20) at 26.52, above the SMA 50 at 24.84, indicating short-term upward momentum. The SMA 200 at 18.72 reflects longer-term growth. The Average True Range (ATR) of 1.82 suggests moderate volatility. On the fundamental side, the trusts market cap of $425.88 million and a price-to-earnings (P/E) ratio of 4.63 indicate undervaluation relative to its earnings. The price-to-book (P/B) ratio of 4.02 and price-to-sales (P/S) ratio of 15.62 highlight a premium valuation relative to book value and sales. The return on equity (RoE) of 96.41% underscores strong profitability.

3-Month Forecast: Based on the technical and fundamental data, Mesabi Trusts stock is expected to trade in a range of $26 to $30 over the next three months. The SMA 20 and SMA 50 suggest continued upward momentum, while the ATR indicates potential price fluctuations of $1.82 on average. Fundamental strength, including high RoE and low P/E, supports a bullish outlook. However, the high P/S ratio may act as a resistance level. The stock is likely to remain sensitive to iron ore prices and broader market conditions.

Additional Sources for MSB Stock

MSB Stock Overview

Market Cap in USD 368m
Sector Basic Materials
Industry Steel
GiC Sub-Industry Steel
IPO / Inception 1987-12-30

MSB Stock Ratings

Growth Rating 61.2
Fundamental -
Dividend Rating 59.3
Rel. Strength 136
Analysts -
Fair Price Momentum 34.24 USD
Fair Price DCF 73.43 USD

MSB Dividends

Dividend Yield 12m 29.37%
Yield on Cost 5y 86.96%
Annual Growth 5y -4.17%
Payout Consistency 73.9%

MSB Growth Ratios

Growth Correlation 3m 30.1%
Growth Correlation 12m 94.6%
Growth Correlation 5y 16.7%
CAGR 5y 28.02%
CAGR/Max DD 5y 0.58
Sharpe Ratio 12m 1.15
Alpha 101.82
Beta 1.143
Volatility 45.47%
Current Volume 60.9k
Average Volume 20d 43.6k
What is the price of MSB stocks?
As of May 01, 2025, the stock is trading at USD 28.99 with a total of 60,939 shares traded.
Over the past week, the price has changed by +3.87%, over one month by +6.58%, over three months by +22.84% and over the past year by +126.15%.
Is Mesabi Trust a good stock to buy?
Yes. Based on ValueRay Analyses, Mesabi Trust (NYSE:MSB) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.16 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSB as of May 2025 is 34.24. This means that MSB is currently undervalued and has a potential upside of +18.11% (Margin of Safety).
Is MSB a buy, sell or hold?
Mesabi Trust has no consensus analysts rating.
What are the forecast for MSB stock price target?
According to ValueRays Forecast Model, MSB Mesabi Trust will be worth about 39.7 in May 2026. The stock is currently trading at 28.99. This means that the stock has a potential upside of +36.98%.
Issuer Forecast Upside
Wallstreet Target Price 33 13.8%
Analysts Target Price 33 13.8%
ValueRay Target Price 39.7 37%